Total Payments
$126,065
2024 Payments
$62,640
Companies
32
Transactions
421
Medicare Patients
710
Medicare Billing
$243,962
Payment Breakdown by Category
Other$58,813 (46.7%)
Consulting$40,526 (32.1%)
Travel$13,469 (10.7%)
Food & Beverage$10,724 (8.5%)
Research$1,694 (1.3%)
Education$763.45 (0.6%)
Gifts$75.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,913 | 17 | 45.9% |
| Consulting Fee | $40,526 | 10 | 32.1% |
| Travel and Lodging | $13,469 | 35 | 10.7% |
| Food and Beverage | $10,724 | 333 | 8.5% |
| Unspecified | $1,694 | 13 | 1.3% |
| Honoraria | $900.00 | 1 | 0.7% |
| Education | $763.45 | 10 | 0.6% |
| Gift | $75.00 | 2 | 0.1% |
Payments by Type
General
$124,371
408 transactions
Research
$1,694
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $71,598 | 82 | $0 (2024) |
| GENZYME CORPORATION | $17,205 | 39 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $16,910 | 65 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $11,984 | 36 | $0 (2019) |
| Ares Trading SA | $2,400 | 1 | $0 (2024) |
| Biogen, Inc. | $1,427 | 48 | $0 (2024) |
| ABBVIE INC. | $934.95 | 46 | $0 (2024) |
| BANNER LIFE SCIENCES, LLC | $900.00 | 1 | $0 (2021) |
| Celgene Corporation | $361.68 | 16 | $0 (2024) |
| Genentech USA, Inc. | $320.16 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,640 | 111 | EMD Serono, Inc. ($58,773) |
| 2023 | $12,907 | 77 | EMD Serono, Inc. ($10,516) |
| 2022 | $979.16 | 41 | Biogen, Inc. ($453.25) |
| 2021 | $1,542 | 32 | BANNER LIFE SCIENCES, LLC ($900.00) |
| 2020 | $426.74 | 10 | Saol Therapeutics Inc. ($162.69) |
| 2019 | $26,514 | 59 | Novartis Pharmaceuticals Corporation ($15,232) |
| 2018 | $8,742 | 46 | GENZYME CORPORATION ($7,876) |
| 2017 | $12,313 | 45 | Teva Pharmaceuticals USA, Inc. ($11,848) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $37.53 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Neurology | ||||||
| 11/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.60 | General |
| 11/20/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $1,242.20 | General |
| Category: Neurology | ||||||
| 11/20/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | Cash or cash equivalent | $65.00 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $57.00 | General |
| 10/31/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Neurology | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/19/2024 | Merz Pharmaceuticals, LLC | AMPYRA (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Multiple Sclerosis | ||||||
| 10/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.11 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neurology | ||||||
| 09/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $103.83 | General |
| 09/16/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 09/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,463.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MS700568-0078 | EMD Serono, Inc. | $1,694 | 13 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 151 | 349 | $226,459 | $34,770 |
| 2022 | 8 | 156 | 6,701 | $370,294 | $66,293 |
| 2021 | 9 | 194 | 7,013 | $393,293 | $66,915 |
| 2020 | 9 | 209 | 8,081 | $477,951 | $75,984 |
Total Patients
710
Total Services
22,144
Medicare Billing
$243,962
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0475 | Injection, baclofen, 10 mg | Office | 2023 | 12 | 95 | $54,625 | $13,375 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 91 | $50,050 | $10,066 | 20.1% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 12 | 42 | $72,954 | $3,163 | 4.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 54 | $14,580 | $2,388 | 16.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $11,900 | $2,016 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 25 | $9,375 | $1,971 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 25 | $12,975 | $1,791 | 13.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 13 | 6,320 | $126,400 | $27,832 | 22.0% |
| J0475 | Injection, baclofen, 10 mg | Office | 2022 | 11 | 115 | $66,125 | $15,907 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 91 | $50,050 | $9,762 | 19.5% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2022 | 11 | 47 | $81,639 | $4,230 | 5.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 61 | $15,255 | $3,315 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 28 | $10,500 | $2,195 | 20.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 25 | $12,975 | $1,681 | 13.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $7,350 | $1,370 | 18.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 6,601 | $132,020 | $26,722 | 20.2% |
| J0475 | Injection, baclofen, 10 mg | Office | 2021 | 17 | 110 | $58,316 | $13,834 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 78 | $42,900 | $8,549 | 19.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 47 | $32,865 | $4,597 | 14.0% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2021 | 17 | 48 | $83,376 | $4,580 | 5.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 72 | $16,200 | $3,838 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 30 | $11,250 | $2,158 | 19.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $9,100 | $1,682 | 18.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 14 | $7,266 | $954.52 | 13.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 14 | 7,625 | $152,500 | $36,716 | 24.1% |
About Dr. Nada Abou-Fayssal, MD
Dr. Nada Abou-Fayssal, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225095292.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nada Abou-Fayssal, MD has received a total of $126,065 in payments from pharmaceutical and medical device companies, with $62,640 received in 2024. These payments were reported across 421 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,913).
As a Medicare-enrolled provider, Abou-Fayssal has provided services to 710 Medicare beneficiaries, totaling 22,144 services with total Medicare billing of $243,962. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Brooklyn, NY
- Active Since 04/26/2006
- Last Updated 03/24/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1225095292
Products in Payments
- Mavenclad (Drug) $29,462
- MAYZENT (Drug) $12,590
- COPAXONE (Drug) $11,569
- AUBAGIO (Drug) $9,191
- LEMTRADA (Drug) $7,876
- Cladribine (Drug) $1,694
- BAFIERTAM (Drug) $900.00
- BOTOX (Biological) $845.23
- TYSABRI (Biological) $606.19
- KESIMPTA (Drug) $586.10
- MAVENCLAD (Drug) $559.73
- VUMERITY (Drug) $519.48
- LIORESAL (Device) $312.45
- ZEPOSIA (Drug) $308.68
- OCREVUS (Biological) $169.14
- Lioresal (baclofen) (Drug) $162.69
- ACTHAR (Biological) $141.09
- BRIUMVI (Drug) $106.40
- LEMTRADA (Biological) $99.99
- Ponvory (Drug) $99.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680
Dr. Daryl Victor, M.d, M.D
Neurology — Payments: $60,707
Neurology $60,707